Applied Finance Capital Management LLC Acquires 5,367 Shares of Stryker Corporation $SYK

Key Points

• Applied Finance Capital Management LLC increased its stake in Stryker Corporation by 15.5%, acquiring an additional 5,367 shares, bringing its total holdings to 39,930 shares valued at approximately $15.8 million.
• Stryker's stock currently has a consensus rating of "Moderate Buy" with a price target of $431.76, following several adjustments by analysts in recent reports.
• The company recently announced a quarterly dividend of $0.84, representing an annual yield of 0.9%, and reported a net margin of 12.25% for the last quarter.

Applied Finance Capital Management LLC lifted its stake in shares of Stryker Corporation (NYSE:SYK - Free Report) by 15.5% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 39,930 shares of the medical technology company's stock after buying an additional 5,367 shares during the quarter. Applied Finance Capital Management LLC's holdings in Stryker were worth $15,797,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of SYK. Sachetta LLC grew its holdings in Stryker by 58.7% in the second quarter. Sachetta LLC now owns 73 shares of the medical technology company's stock worth $29,000 after purchasing an additional 27 shares during the period. Goodman Advisory Group LLC acquired a new position in shares of Stryker during the first quarter valued at about $32,000. Ridgewood Investments LLC boosted its position in shares of Stryker by 48.4% during the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company's stock worth $36,000 after purchasing an additional 30 shares in the last quarter. Ransom Advisory Ltd acquired a new stake in shares of Stryker in the 1st quarter valued at about $37,000. Finally, Smallwood Wealth Investment Management LLC bought a new stake in Stryker in the 1st quarter valued at about $40,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Redburn Partners set a $420.00 price target on Stryker in a research note on Thursday, September 18th. UBS Group set a $408.00 price objective on Stryker in a report on Monday. Truist Financial cut their target price on Stryker from $415.00 to $407.00 and set a "hold" rating on the stock in a report on Wednesday. Weiss Ratings restated a "buy (b-)" rating on shares of Stryker in a research note on Wednesday, October 8th. Finally, Evercore ISI dropped their price objective on shares of Stryker from $418.00 to $410.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 7th. Fifteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $431.76.

Stryker Price Performance

Shares of NYSE:SYK opened at $369.05 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. The stock's fifty day simple moving average is $379.46 and its two-hundred day simple moving average is $378.76. Stryker Corporation has a 1-year low of $329.16 and a 1-year high of $406.19. The stock has a market cap of $141.09 billion, a PE ratio of 48.88, a price-to-earnings-growth ratio of 2.66 and a beta of 0.94.

Stryker (NYSE:SYK - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.07 by $0.06. The firm had revenue of $6.02 billion during the quarter, compared to analyst estimates of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The business's revenue was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, analysts forecast that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a $0.84 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $3.36 annualized dividend and a yield of 0.9%. Stryker's dividend payout ratio (DPR) is 44.50%.

Insider Activity at Stryker

In related news, insider Viju Menon sold 500 shares of Stryker stock in a transaction on Monday, August 25th. The stock was sold at an average price of $390.61, for a total transaction of $195,305.00. Following the sale, the insider directly owned 12,511 shares in the company, valued at approximately $4,886,921.71. This trade represents a 3.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Ronda E. Stryker sold 200,000 shares of the business's stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the completion of the transaction, the director directly owned 3,222,108 shares in the company, valued at approximately $1,212,962,556.60. This represents a 5.84% decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is owned by company insiders.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.